| 000 | 01053 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516164927.0 | ||
| 264 | 0 | _c20140303 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1744-7623 | ||
| 024 | 7 |
_a10.1517/14728214.2013.832754 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTibes, Raoul | |
| 245 | 0 | 0 |
_aEmerging drugs for polycythemia vera. _h[electronic resource] |
| 260 |
_bExpert opinion on emerging drugs _cSep 2013 |
||
| 300 |
_a393-404 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPolycythemia Vera _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 700 | 1 | _aMesa, Ruben A | |
| 773 | 0 |
_tExpert opinion on emerging drugs _gvol. 18 _gno. 3 _gp. 393-404 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728214.2013.832754 _zAvailable from publisher's website |
| 999 |
_c23025887 _d23025887 |
||